Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
This bill creates a certification process for organizations providing in-home substance use disorder treatment services in New York. It requires applicants (including out-of-state entities registered with the state) to meet specific clinical standards, including conducting screenings for overdose risk, mental health conditions, and suicide risk. Certified providers must implement safety plans, medication-assisted treatment, naloxone access, and regular recovery planning. The law aims to standardize and expand access to in-home treatment while ensuring providers meet defined safety and clinical requirements.
Establishes an intensive addiction and medical services integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and medical services integrated services to individuals who have significant addiction and medical issues.
Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.
Directs the department of health to establish an alternative payment methodology (APM) for federally qualified health centers to preserve and improve patient access to fertility care.
S 4497 requires certain health insurance policies to cover fertility preservation services, such as egg or sperm freezing, for individuals facing medical treatments that may cause infertility (like cancer therapy). This directly affects patients undergoing procedures with known fertility risks and the insurance companies offering those plans. The bill mandates coverage for these services before treatment begins, ensuring individuals can preserve fertility options without excessive out-of-pocket costs. It applies to standard health insurance policies, not just specialized plans, aiming to make these services accessible during critical medical care.
This bill (S 3155) requires health insurers to provide in vitro fertilization (IVF) coverage without discrimination. It prohibits insurers from denying or limiting IVF coverage based on factors like age, disability, sexual orientation, gender identity, or perceived quality of life. The bill specifically bans insurers from requiring all embryos from a previous IVF cycle to be transferred before covering a subsequent cycle for women aged 35 or older. These changes directly affect individuals seeking IVF treatment by expanding access and preventing discriminatory practices in insurance coverage.
This bill allows New York pharmacists to administer FDA-approved progestin-only contraceptive injections, expanding access to this specific form of birth control. It requires pharmacists to complete training, provide patient screening questionnaires and fact sheets about clinical considerations, and notify a patient's primary care provider (unless the patient opts out). The policy directly affects patients seeking contraception and pharmacists who will administer the injections. Key safety mechanisms include mandatory screenings, provider notifications, and pharmacist discretion to refuse service if health risks are identified.
S 3759 establishes state standards and oversight for social adult day services programs that support functionally impaired seniors (those needing help with daily tasks like eating, moving, or supervision due to cognitive issues). It requires the state director to set rules for services, staffing, and inspections (initial and every five years), with programs needing certification to operate. The bill also details funding: providing 75% state grants (with a possible 100% grant for financially needy providers) for eligible programs, while prohibiting duplication of existing federal or state funding. This directly affects nonprofit and local government providers of these services and the elderly individuals receiving care in community-based settings.
Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.
